TITLE

Immune cells may fend off Alzheimer disease

AUTHOR(S)
Britschgi, Markus; Wyss-Coray, Tony
PUB. DATE
April 2007
SOURCE
Nature Medicine;Apr2007, Vol. 13 Issue 4, p408
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the findings of a research on the possibility that immune processes may limit Alzheimer disease. In a mouse model of the disease, a specific chemokine receptor was discovered which facilitated the recruitment of microglia from within the brain, and monocytes from the blood to deposits of a neurotoxic peptide that accumulates in the brains of patients with Alzheimer disease.
ACCESSION #
24629909

 

Related Articles

  • Assessing Activation States in Microglia. Colton, Carol A.; Wilcock, Donna M. // CNS & Neurological Disorders - Drug Targets;Apr2010, Vol. 9 Issue 2, p174 

    Since the original identification of microglia as a principal player in the brain's innate immune response, microglial activation has been widely studied. Recent studies suggest that microglial responses are heterogeneous, requiring a more precise definition of the functional outcomes of their...

  • Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. Jing-Ji Jin; Hong-Duck Kim; Maxwell, J. Adam; Ling Li; Fukuchi, Kenichiro // Journal of Neuroinflammation;2008, Vol. 5, Special section p1 

    Background: Aβ deposits in the brains of patients with Alzheimer's disease (AD) are closely associated with innate immune responses such as activated microglia and increased cytokines. Accumulating evidence supports the hypothesis that innate immune/inflammatory responses play a pivotal role...

  • Alzheimer's Disease: Blocking Receptor Halts Loss of Neurons. Kingman, Sharon // BioWorld International;3/31/2010, Vol. 15 Issue 13, p1 

    The article discusses research on the possible role of a chemokine receptor present on the surface of microglial cells in the brain as treatment for Alzheimer's disease (AD). It references a study by Martin Furhmann et al, published in the March 22, 2010 issue of the journal "Nature...

  • CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. Kowarik, Markus C.; Cepok, Sabine; Sellner, Johann; Grummel, Verena; Weber, Martin S.; Korn, Thomas; Berthele, Achim; Hemmer, Bernhard // Journal of Neuroinflammation;2012, Vol. 9 Issue 1, p93 

    Background: The chemokines and cytokines CXCL13, CXCL12, CCL19, CCL21, BAFF and APRIL are believed to play a role in the recruitment of B cells to the central nervous system (CNS) compartment during neuroinflammation. To determine which chemokines/cytokines show the strongest association with a...

  • Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion. Renner, Nicole; Sansing, Hope; Morici, Lisa; Inglis, Fiona; Lackner, Andrew; MacLean, Andrew // Journal of NeuroVirology;Jun2012, Vol. 18 Issue 3, p213 

    HIV infection in the brain and the resultant encephalitis affect approximately one third of individuals infected with HIV, regardless of treatment with antiretroviral drugs. Microglia are the resident phagocytic cell type in the brain, serving as a 'first responder' to neuroinvasion by...

  • Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain. Ramesh, Geeta; MacLean, Andrew G.; Philipp, Mario T. // Mediators of Inflammation;2013, Vol. 2013, p1 

    Cytokines and chemokines are proteins that coordinate the immune response throughout the body. The dysregulation of cytokines and chemokines is a central feature in the development of neuroinflammation, neurodegeneration, and demyelination both in the central and peripheral nervous systems and...

  • How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease. Rezai-Zadeh, K.; Gate, D.; Gowing, G.; Town, T. // Current Alzheimer Research;Mar2011, Vol. 8 Issue 2, p156 

    No abstract available.

  • Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. Colton, Carol A.; Mott, Ryan T.; Sharpe, Hayley; Qing Xu; Van Nostrand, William E.; Vitek, Michael P. // Journal of Neuroinflammation;2006, Vol. 3, p27 

    Background: Microglia are associated with neuritic plaques in Alzheimer disease (AD) and serve as a primary component of the innate immune response in the brain. Neuritic plaques are fibrous deposits composed of the amyloid beta-peptide fragments (Abeta) of the amyloid precursor protein (APP)....

  • Immune attack: the role of inflammation in Alzheimer disease. Heppner, Frank L.; Ransohoff, Richard M.; Becher, Burkhard // Nature Reviews Neuroscience;Jun2015, Vol. 16 Issue 6, p358 

    The past two decades of research into the pathogenesis of Alzheimer disease (AD) have been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with AD has been assumed to be merely a response to pathophysiological events. However, new data from preclinical and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics